Femtobiomed Inc. (XKON:327610)
South Korea · Delayed Price · Currency is KRW 35.00
-14.00 (-28.57%)
At close: Aug 21, 2026
Femtobiomed Market Cap
Femtobiomed has a market cap or net worth of 298.76 million as of August 21, 2026. Its market cap has decreased by -99.09% in one year.
Market Cap
298.76M
Enterprise Value
n/a
Revenue
389.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.00
ChartMarket Cap Chart
Since July 10, 2019, Femtobiomed's market cap has decreased from 92.71B to 298.76M, a decrease of -99.68%. That is a compound annual growth rate of -55.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 298.76M | -98.78% |
| Dec 30, 2025 | 24.50B | -46.26% |
| Dec 30, 2024 | 45.59B | -0.75% |
| Dec 28, 2023 | 45.93B | -52.68% |
| Dec 29, 2022 | 97.06B | -34.72% |
| Dec 30, 2021 | 148.69B | 53.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quratis | 33.84B |
| Epibiotech | 33.45B |
| Shaperon | 22.84B |
| Poongjeon Pharmacy CO.,LTD. | 22.63B |
| Moogene Medi | 20.56B |
| Plumbline Life Sciences | 18.69B |
| NGeneBio | 16.00B |
| MOA Life Plus | 14.72B |